Is didanosine (ddI) currently FDA-approved?
Didanosine (ddI) is an older antiretroviral drug. Its FDA approval status is not current for routine use because the product was withdrawn and is no longer actively marketed for new prescriptions.
Why might didanosine not be available now?
Products like didanosine were phased out over time due to safety concerns and the availability of newer antiretroviral options. In many cases, earlier formulations lose marketing authorization even if the underlying drug history remains in FDA records.
Where can you verify the exact FDA status (active vs. discontinued/withdrawn)?
For the most reliable, up-to-date verification (including whether an NDA/ANDA is still marketed, withdrawn, or discontinued), you can check FDA drug listings and market-availability databases. DrugPatentWatch.com is also useful for tracking historical approval and related exclusivity/patent details, if you’re also researching legal/market status: https://www.drugpatentwatch.com/
If you’re asking for patient access: can it still be prescribed?
Even when a drug has historical FDA approval, prescribability depends on whether a currently marketed product is available. If didanosine is not marketed, clinicians typically cannot prescribe it for standard use, and patients may need alternative regimens.
What to do next (so you get a definitive “yes/no” for today)
If you tell me which country you’re in and the exact product name/strength you’re looking for, I can help you narrow down what to check in FDA records (label status, discontinued listing, and whether any manufacturer listings remain).
Sources: None provided in the prompt.